Skip to content
Home/Companies/MedTech/Atlantic Therapeutics

Atlantic Therapeutics

MedTech·Ireland·Exited 2023·Held 5yr
Entry
2018
Hold
5yr
Exit
2023

Who owns Atlantic Therapeutics?

Atlantic Therapeutics is an Irish MedTech company, now owned by Caldera Medical, which acquired it in 2023 from Atlantic Bridge Capital and Andera Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Andera Partners
Most recent investor
Andera Partners
BioDiscovery 5 · 2017 · VC
2 ownership periods · full history below

Key facts

HQIreland
SectorMedTech
Key takeaways
  • ·Fully exited in 2023 to Caldera Medical.
  • ·Average hold across 2 realized cycles: 5 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2023 to Caldera Medical.
Co-invest · 2 holders · 2018 · 2023
Atlantic Bridge Capital
2018 · 2023(5yr) · Atlantic Bridge III · 2016 · Growth
Trade Sale · to Caldera Medical

Atlantic Bridge Capital sold Atlantic Therapeutics to Caldera Medical in 2023 after 5 years.

Andera Partners
Andera PartnersExited 2023
2018 · 2023(5yr) · BioDiscovery 5 · 2017 · VC
Trade Sale · to Caldera Medical

Andera Partners sold Atlantic Therapeutics to Caldera Medical in 2023 after 5 years.

Questions

Who owns Atlantic Therapeutics?

Atlantic Therapeutics is now owned by Caldera Medical, which acquired it in 2023 from Atlantic Bridge Capital and Andera Partners.

When did Caldera Medical acquire Atlantic Therapeutics?

Caldera Medical acquired Atlantic Therapeutics in 2023, buying from Atlantic Bridge Capital and Andera Partners.

Who did Atlantic Therapeutics sell to?

Atlantic Bridge Capital and Andera Partners sold Atlantic Therapeutics to Caldera Medical in 2023 (Trade Sale).

Who has owned Atlantic Therapeutics over time?

Atlantic Therapeutics has been through 2 private-equity ownership periods: Atlantic Bridge Capital · via Atlantic Bridge III · 2018–2023 · sold to Caldera Medical · (Trade Sale); Andera Partners · via BioDiscovery 5 · 2018–2023 · sold to Caldera Medical · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue